A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Taiwan condemns China, Russia for undermining peace with military actions
11/29/2024 11:13 PM - Cross-Strait
Chinese Olympic champion visits Taipei university for table tennis exchange
11/29/2024 11:02 PM - Society
Taiwan expected to see colder, drier winter
11/29/2024 10:32 PM - Business
Taiwan's 2024 GDP growth forecast raised to 4.27%
11/29/2024 09:56 PM - Society
6 health ministry officials investigated for workplace bullying
11/29/2024 09:26 PM